Canada-UK: Biomanufacturing of Biologics and Advanced Therapies

UK registered organisations can apply for a share of up to £3.5 million for collaboration with Canadian SMEs on joint R&D projects, for enabling technologies and innovations in biomanufacturing of biologics and advanced therapies.

Innovate UK, part of UK Research and Innovation, will work with the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to invest up to £3.5 million in innovation projects.

The aim of this competition is to stimulate the development and implementation of innovative technologies in biomanufacturing. The objective is to build the desired flexibility and technical capabilities required for the development and economically sustainable production of the next generation vaccines and therapies.

The bilateral research and development (R&D) collaborations between UK and Canada will enable both countries to be well positioned to respond to future health emergencies.

Your proposal must contribute to the development of innovative technology that enables flexible, scalable, efficient and cost effective manufacturing of novel biological therapeutic products and delivery systems. It must demonstrate high potential for commercialisation.